Research and Markets: Thyroid Cancer - Pipeline Review, H2 2012

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/dxgj2r/thyroid_cancer) has announced the addition of Global Markets Direct's new report "Thyroid Cancer - Pipeline Review, H2 2012" to their offering.

“Thyroid Cancer - Pipeline Review, H2 2012”

Global Markets Direct's, 'Thyroid Cancer - Pipeline Review, H2 2012', provides an overview of the indication's therapeutic pipeline. This report provides information on the therapeutic development for Thyroid Cancer, complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Thyroid Cancer. Thyroid Cancer - Pipeline Review, Half Year is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team.

Scope

- A snapshot of the global therapeutic scenario for Thyroid Cancer.

- A review of the Thyroid Cancer products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.

- Coverage of products based on various stages of development ranging from discovery till registration stages.

- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.

- Coverage of the Thyroid Cancer pipeline on the basis of route of administration and molecule type.

- Key discontinued pipeline projects.

- Latest news and deals relating to the products.

Companies Mentioned:

- F. Hoffmann-La Roche Ltd.

- AstraZeneca PLC

- Daiichi Sankyo Company, Ltd

- Takeda Pharmaceutical Company Limited

- Plexxikon Inc.

- Bio-Path Holdings, Inc.

- Novartis AG

- Eisai Co., Ltd.

- Pfizer Inc.

- Exelixis, Inc.

- Bayer AG

- OXiGENE, Inc.

- Azaya Therapeutics, Inc.

- Vascular Biogenics Ltd.

- Globeimmune, Inc.

- Genelux Corporation

- Trophogen, Inc.

For more information visit http://www.researchandmarkets.com/research/dxgj2r/thyroid_cancer

Source: Global Markets Direct

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Oncology

Recent Stories

Research and Markets: Shire Partnering 2005-2013 Provides the User with the Tools to Make Successful Contact with the Right Partners Effectively and Efficiently

May 17, 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/hsh77t/shire_partnering) has announced the addition of the "Shire Partnering 2005-2013" company profile to ... more »
Research and Markets: Allergic Rhinitis Partnering 2007-2013 Contains Over 120 Links to Online Copies of Actual Allergic Rhinitis Deals and Contract Documents

May 17, 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/zpxmg2/allergic_rhinitis) has announced the addition of the "Allergic Rhinitis Partnering 2007-2013" report... more »
Research and Markets: Patentfax - Worldwide Dental Patent Download Service: 2013

May 17, 2013

DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/cmcdnr/patentfax) has announced the addition of the "Patentfax - Worldwide Dental Patent Download Service" ... more »